These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1662813)
21. An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. Song S; Wang Y; Bak SY; Lang P; Ullrey D; Neve RL; O'Malley KL; Geller AI J Neurochem; 1997 May; 68(5):1792-803. PubMed ID: 9109503 [TBL] [Abstract][Full Text] [Related]
22. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Ho DY; McLaughlin JR; Sapolsky RM Brain Res Mol Brain Res; 1996 Sep; 41(1-2):200-9. PubMed ID: 8883953 [TBL] [Abstract][Full Text] [Related]
23. A herpes simplex virus-1 vector containing the rat tyrosine hydroxylase promoter directs cell type-specific expression of beta-galactosidase in cultured rat peripheral neurons. Oh YJ; Moffat M; Wong S; Ullrey D; Geller AI; O'Malley KL Brain Res Mol Brain Res; 1996 Jan; 35(1-2):227-36. PubMed ID: 8717359 [TBL] [Abstract][Full Text] [Related]
24. Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain. Pakzaban P; Geller AI; Isacson O Hum Gene Ther; 1994 Aug; 5(8):987-95. PubMed ID: 7948148 [TBL] [Abstract][Full Text] [Related]
25. Introduction of a foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: a light and electron microscopic study. Huang Q; Vonsattel JP; Schaffer PA; Martuza RL; Breakefield XO; DiFiglia M Exp Neurol; 1992 Mar; 115(3):303-16. PubMed ID: 1311266 [TBL] [Abstract][Full Text] [Related]
26. Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector. Jin BK; Belloni M; Conti B; Federoff HJ; Starr R; Son JH; Baker H; Joh TH Hum Gene Ther; 1996 Oct; 7(16):2015-24. PubMed ID: 8930662 [TBL] [Abstract][Full Text] [Related]
27. Herpes simplex virus type 1 vector mediated gene transfer to muscle. Huard J; Goins WF; Glorioso JC Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113 [TBL] [Abstract][Full Text] [Related]
29. Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults. Ho DY; Saydam TC; Fink SL; Lawrence MS; Sapolsky RM J Neurochem; 1995 Aug; 65(2):842-50. PubMed ID: 7616244 [TBL] [Abstract][Full Text] [Related]
30. Gene transfer into mammalian central nervous system using herpes virus vectors: extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter. Andersen JK; Garber DA; Meaney CA; Breakefield XO Hum Gene Ther; 1992 Oct; 3(5):487-99. PubMed ID: 1329993 [TBL] [Abstract][Full Text] [Related]
31. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218 [TBL] [Abstract][Full Text] [Related]
32. In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Fink DJ; Sternberg LR; Weber PC; Mata M; Goins WF; Glorioso JC Hum Gene Ther; 1992 Feb; 3(1):11-9. PubMed ID: 1314100 [TBL] [Abstract][Full Text] [Related]
33. Herpesviruses: expression of genes in postmitotic brain cells. Geller AI Curr Opin Genet Dev; 1993 Feb; 3(1):81-5. PubMed ID: 8384036 [TBL] [Abstract][Full Text] [Related]
34. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS. McMenamin MM; Byrnes AP; Pike FG; Charlton HM; Coffin RS; Latchman DS; Wood MJ Gene Ther; 1998 May; 5(5):594-604. PubMed ID: 9797863 [TBL] [Abstract][Full Text] [Related]
35. Gene transfer into enteric neurons of the rat small intestine in organ culture using a replication defective recombinant herpes simplex virus type 1 (HSV1) vector, but not recombinant adenovirus vectors. Brown OA; Santer RM; Shering AF; Larregina AT; Morelli AE; Southgate TD; Castro MG; Lowenstein PR Gene Ther; 1997 Apr; 4(4):331-8. PubMed ID: 9176519 [TBL] [Abstract][Full Text] [Related]
36. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector. Warden MP; Weir JP Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330 [TBL] [Abstract][Full Text] [Related]
37. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. During MJ; Naegele JR; O'Malley KL; Geller AI Science; 1994 Nov; 266(5189):1399-403. PubMed ID: 7669103 [TBL] [Abstract][Full Text] [Related]
38. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Wood MJ; Byrnes AP; Pfaff DW; Rabkin SD; Charlton HM Gene Ther; 1994 Sep; 1(5):283-91. PubMed ID: 7584093 [TBL] [Abstract][Full Text] [Related]
39. Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector. Watanabe D; Brockman MA; Ndung'u T; Mathews L; Lucas WT; Murphy CG; Felber BK; Pavlakis GN; Deluca NA; Knipe DM Virology; 2007 Jan; 357(2):186-98. PubMed ID: 16996101 [TBL] [Abstract][Full Text] [Related]
40. Defective herpes simplex virus vectors for the study of promoter and gene function in the CNS. New KC; Martuza RL; Rabkin SD Gene Ther; 1994; 1 Suppl 1():S79. PubMed ID: 8542425 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]